Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

206

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

April 2, 2022

Study Completion Date

July 22, 2022

Conditions

Dry Eye Disease

Interventions

DRUG

SHR8028 eye drops

DRUG

Vehicle eye drops.

Trial Locations (1)

Peking University Third Hospital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05841043 - Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease | Biotech Hunter | Biotech Hunter